Akebia Therapeutics AKBA Income Statements

Conto economico

Quarter End	Mar 2022	Giu 2022	Set 2022	Dic 2022	Mar 2023	Giu 2023	Set 2023	Dic 2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Entrate totali	61,7M	126,76M	48,96M	55,18M	40,13M	56,25M	42,05M	56,2M
Reddito operativo	-58,49M	33,9M	-48,17M	-6,35M	-24,94M	-9,66M	-13,04M	1,37M
Reddito ante imposte	-62,42M	29,28M	-51,87M	-7,55M	-26,22M	-11,83M	-14,49M	614k
Reddito netto	-62,42M	29,28M	-51,87M	-7,55M	-26,22M	-11,83M	-14,49M	614k
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	0	0	0	0	0	0	0	0
UTILE OPERATIVO	-57,36M	34,31M	-47,01M	-5,92M	-24,66M	-10,19M	-13,08M	2,03M
EBITDA	-49,07M	43,33M	-38,75M	3,07M	-15,53M	-249k	-3,63M	10,78M

Fine anno 31 Dicembre 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Entrate totali	1,54M	177,98M	207,74M	335M	295,31M	213,58M	292,6M	194,62M
Reddito operativo	-136,46M	-79,92M	-178,16M	-286,29M	-376,44M	-265,32M	-79,12M	-46,26M
Reddito ante imposte	-135,75M	-76,91M	-171,93M	-286,29M	-383,46M	-282,84M	-92,56M	-51,93M
Reddito netto	-135,75M	-76,91M	-143,59M	-279,66M	-383,46M	-282,84M	-92,56M	-51,93M
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	-3.515	-1.615	-1.228	-2.298	-2.59	-1.598	-0.503	-0.276
UTILE OPERATIVO	-136,65M	-79,71M	-178,08M	-287,08M	-374,59M	-262,9M	-75,97M	-45,89M
EBITDA	-136,17M	-79,3M	-175,75M	-247,64M	-227,3M	-227,35M	-41,42M	-8,63M